Abstract 1199: NSCLC KRAS G12C and G12V mutations drive different pathways and display specific drug sensitivity patterns.


Journal Article

Full Text

Duke Authors

Cited Authors

  • Ferte, C; Guinney, J; Derry, J; huang, EH; Besse, B; Soria, J-C

Published Date

  • April 15, 2013

Published In

  • Clinical Research

Published By

Digital Object Identifier (DOI)

  • 10.1158/1538-7445.am2013-1199